Oxford GlycoSciences has filed patent applications on 4,000 disease-associated proteins, protein isoforms, and their genes, accomplishing a goal the company set for itself in March 2000, the Abingdon, UK-based company said Dec. 7.
OGS Files Patent Applications on 4,000 Proteins In Symbol of Transition into Drug Development
Premium
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.